Form 4 for BCPC BALCHEM CORP
Accepted 2023-05-04 00:00:00 ET · period of report 2023-05-02 · accession 0001140361-23-022963 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-04 | 2023-05-02 | BCPC | Sestrick Michael Robert | SVP, CTO | S - Sale | $130.36 | -2,300 | 5,424 | -30% | -$299.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-02 | S | D | 2,300 | $130.36 | 5,424 | D | — | — | (F1) This transaction was executed in multiples sales ranging from $129.9700 to $130.9000 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote. (F2) Includes acquisition of shares under the Balchem Corporation 401(k) plan. |